157 related articles for article (PubMed ID: 24172912)
1. Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis.
Li Y; Liu L; Wang B; Wang J; Chen D
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):332-8. PubMed ID: 24172912
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
[TBL] [Abstract][Full Text] [Related]
4. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
5. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Bartuli A; Manco M; Lopez R; Alisi A; Feldstein AE
Pediatr Res; 2010 Jun; 67(6):665-70. PubMed ID: 20496475
[TBL] [Abstract][Full Text] [Related]
6. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
Alkhouri N; Sedki E; Alisi A; Lopez R; Pinzani M; Feldstein AE; Nobili V
Liver Int; 2013 Jan; 33(1):79-85. PubMed ID: 23146095
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
Milner KL; van der Poorten D; Xu A; Bugianesi E; Kench JG; Lam KS; Chisholm DJ; George J
Hepatology; 2009 Jun; 49(6):1926-34. PubMed ID: 19475694
[TBL] [Abstract][Full Text] [Related]
8. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
[TBL] [Abstract][Full Text] [Related]
9. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
[TBL] [Abstract][Full Text] [Related]
10. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
[TBL] [Abstract][Full Text] [Related]
11. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Padovani R; Rodella S; Zoppini G; Zenari L; Cigolini M; Falezza G; Arcaro G
Diabetes Care; 2006 Jun; 29(6):1325-30. PubMed ID: 16732016
[TBL] [Abstract][Full Text] [Related]
12. LPIN1 rs13412852 polymorphism in pediatric nonalcoholic fatty liver disease.
Valenti L; Motta BM; Alisi A; Sartorelli R; Buonaiuto G; Dongiovanni P; Rametta R; Pelusi S; Fargion S; Nobili V
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):588-93. PubMed ID: 22157924
[TBL] [Abstract][Full Text] [Related]
13. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease.
Chandok N; Minuk G; Wengiel M; Uhanova J
J Gastrointestin Liver Dis; 2012 Mar; 21(1):53-8. PubMed ID: 22457860
[TBL] [Abstract][Full Text] [Related]
14. Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Verrijken A; Francque S; Mertens I; Prawitt J; Caron S; Hubens G; Van Marck E; Staels B; Michielsen P; Van Gaal L
Hepatology; 2014 Jan; 59(1):121-9. PubMed ID: 24375485
[TBL] [Abstract][Full Text] [Related]
15. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
16. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease.
Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE
Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
[TBL] [Abstract][Full Text] [Related]
18. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD.
Boursier J; Chaigneau J; Roullier V; Lainé F; Sandrini J; Michalak S; Hubert I; Dib N; Oberti F; Bertrais S; Hunault G; Deugnier Y; Rousselet MC; Cavaro-Ménard C; Gallois Y; Aubé C; Calès P;
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):974-81. PubMed ID: 21904208
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
[TBL] [Abstract][Full Text] [Related]
20. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]